US FDA approves Novartis' kidney disease drug-February 2024-www.financetom.com

US FDA approves Novartis' kidney disease drug

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

US FDA approves Novartis' kidney disease drug

Aug 7, 2024 11:54 AM

Aug 7 (Reuters) - The U.S. Food and Drug Administration

has approved the use of Novartis' drug to treat

patients with a type of kidney disease, the health regulator's

website showed on Wednesday.

Previous page： Investcorp India Completes Due Diligence in Bigtincan Deal Next page： Domino's Pizza Q3 Results 'Mixed,' 2025 View May be a 'De-Risking Event,' Morgan Stanley Says

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Investcorp India Completes Due Diligence in Bigtincan Deal

Oct 11, 2024

11:39 AM EDT, 10/11/2024 (MT Newswires) -- Investcorp India Acquisition ( IVCA ) said Friday it has completed diligence and negotiations with Bigtincan Holdings as part of its proposed business combination. Under the proposed offer, all the shares in Bigtincan Holdings will be exchanged for equity in a new Cayman Islands company called Bigtincan Ltd. with an implied equity value...

Domino's Pizza Q3 Results 'Mixed,' 2025 View May be a 'De-Risking Event,' Morgan Stanley Says

Oct 11, 2024

11:37 AM EDT, 10/11/2024 (MT Newswires) -- Domino's Pizza's (DPZ) Q3 results were mixed and the lighter 2025 view may be a de-risking event that could be deemed conservative, Morgan Stanley said in a note to clients Friday. On Thursday, the company reported Q3 earnings of $4.19 per share, up from $4.18 a year earlier. Revenue for the quarter was...

Biora Therapeutics Board Approves 1-for-10 Reverse Stock Split

Oct 11, 2024

11:39 AM EDT, 10/11/2024 (MT Newswires) -- Biora Therapeutics ( BIOR ) said Friday its board has approved a 1-for-10 reverse stock split as well as a reduction in the total number of authorized common shares to 255 million from 300 million. The reverse split will take effect on Oct. 18, when the stock will begin trading on a split-adjusted...

Update: Velan Surges 12% as It Swings to an Adjusted Profit in Fiscal Q2

Oct 11, 2024

11:43 AM EDT, 10/11/2024 (MT Newswires) -- Velan ( VLNSF ) , a manufacturer of industrial valves, late on Thursday said it swung to an adjusted profit in its fiscal second quarter, driven by higher sales. For the quarter ended Aug. 31, its adjusted profit, excluding most one-time items, was US$121,000, or US$0.01, per share, compared with a loss of...